Lineage Cell Therapeutics, Inc. Common Stock (LCTX) SBC to Revenue & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · SBC to Revenue

LCTX SBC to Revenue

Current (TTM)38.75%retrievedOct 20, 2026

LCTX SBC/Revenue (0.00% → 38.75%)

Latest values, visible window

High-resolution chart · PNG

LCTX sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock SBC to Revenue — Annual fiscal periods
Period ending	SBC to Revenue
Dec 31, 2025	32.6463%
Dec 31, 2024	53.4477%
Dec 31, 2023	51.8726%
Dec 31, 2022	29.1573%
Dec 31, 2021	90.3234%
Dec 31, 2020	288.0983%
Dec 31, 2019	242.2192%
Dec 31, 2018	381.4972%
Dec 31, 2017	219.4196%
Dec 31, 2016	353.0639%
Dec 31, 2015	436.0695%
Dec 31, 2014	228.909%
Dec 31, 2013	112.4735%
Dec 31, 2012	75.7594%
Dec 31, 2011	27.9584%
Dec 31, 2010	17.3548%
Dec 31, 2009	25.3777%
Dec 31, 2008	8.9453%
Dec 31, 2007	14.4399%
Dec 31, 2006	0%
Dec 31, 2005	9.8736%
Dec 31, 2004	0%
Dec 31, 2003	0%
Dec 31, 2002	49.5892%
Dec 31, 2001	0%
Dec 31, 2000	0%
Dec 31, 1999	0%
Dec 31, 1998	0%
Jun 30, 1998	0%
Jun 30, 1996	0%
Jun 30, 1995	0%
Jun 30, 1994	0%
Jun 30, 1993	0%
Jun 30, 1992	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.